Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,729.00
(
0.30%
)
News Focus
News Focus
Post# of 257266
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

io_io

Send PM Follow Ignore
Followers 63
Posts 5557
Boards Moderated 0
Alias Born 01/17/2005

io_io

Re: DewDiligence post# 16878

Thursday, 10/13/2005 8:07:14 PM

Thursday, October 13, 2005 8:07:14 PM

Post# of 257266
GTCB

Do we have any idea what GTCB's cut would be if one of it's partner's drugs was to enter the market post-approval ?

Obviously a good prosiasis drug might garner $500m to $1bn depending upon efficacy. If the goats are a low-cost solution, might GTCB's cut be say high single digits or low double digits ?

"....on the biotech battle-field, you need some élan...."

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today